+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Office Based Labs Market by Technology Type (Clinical Chemistry, Coagulation & Hemostasis, Hematology), Test Type (Point-of-Care Tests, Routine Tests, Specialized Tests), Product Type, Application, End User - Global Forecast 2025-2030- Product Image
Office Based Labs Market by Technology Type (Clinical Chemistry, Coagulation & Hemostasis, Hematology), Test Type (Point-of-Care Tests, Routine Tests, Specialized Tests), Product Type, Application, End User - Global Forecast 2025-2030- Product Image
Sale

Office Based Labs Market by Technology Type (Clinical Chemistry, Coagulation & Hemostasis, Hematology), Test Type (Point-of-Care Tests, Routine Tests, Specialized Tests), Product Type, Application, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 192 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5470716
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Senior executives seeking actionable intelligence on the evolving office based labs market will find this report an indispensable resource for benchmarking strategic opportunities, assessing risks, and pinpointing new avenues for operational excellence in the diagnostic laboratory sector.

Market Snapshot: Office Based Labs Market Growth

The office based labs market grew from USD 50.64 billion in 2024 to USD 55.16 billion in 2025. It is projected to continue expanding at a CAGR of 8.59%, reaching USD 83.05 billion by 2030. This substantial momentum reflects accelerated advancements in laboratory automation, increased demand for rapid diagnostics, and diversified testing services aligned with broader healthcare trends.

Scope & Segmentation

This report provides a granular breakdown of the market, giving decision-makers clarity on technology landscape and regional growth patterns. The segmentation addresses all key categories shaping the competitive and operational dynamics:

  • Technology Type: Clinical chemistry (continuous flow, discrete analyzers), coagulation and hemostasis (platelet function testing, prothrombin time INR), hematology (automated analyzers, manual cell counters), immunoassay (chemiluminescence, enzyme-linked immunoassay), molecular diagnostics (FISH, next-generation sequencing, PCR).
  • Test Type: Point-of-care (glucose, lipid testing), routine tests (basic, comprehensive panels), specialized tests (biomarker, genetic tests).
  • Product Type: Automated analyzers (discrete, integrated), next-generation sequencing (targeted panel, whole genome), point-of-care devices (benchtop, handheld).
  • Application: Disease monitoring (acute, chronic), healthcare diagnostics (infectious diseases, oncology), preventive screening (cardiovascular, metabolic).
  • End User: Hospital outreach laboratories, independent reference laboratories, physician office laboratories.
  • Geographic Regions: Americas (including major U.S. states and leading economies in Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (UK, Germany, France, Russia, Italy, Spain, UAE, Saudi Arabia, and others), Asia-Pacific (China, India, Japan, Australia, South Korea, and additional emerging markets).
  • Key Companies: F. Hoffmann-La Roche Ltd, Danaher Corporation, Abbott Laboratories, Thermo Fisher Scientific Inc., Siemens Healthineers AG, Sysmex Corporation, Becton, Dickinson and Company, bioMérieux SA, QIAGEN N.V., Ortho Clinical Diagnostics Inc.

Key Takeaways: Strategic Insights for Decision-Makers

  • Office based laboratories are transitioning from adjunct services to critical partners in healthcare delivery, now integrating with clinicians and technology providers for holistic patient care.
  • Technological advancement, including automation and digital pathology, is streamlining workflows, reducing manual intervention, and enabling real-time data connectivity for improved diagnostic outcomes.
  • Mergers, acquisitions, and strategic partnerships are driving consolidation and broadening market access, supporting facilities in accommodating new test types and specialized services.
  • Segment expansion into specialized testing, such as oncology and genetic diagnostics, reflects increased complexity in clinical demand and requires new investments in advanced instrumentation.
  • Regional variations are significant: established markets pursue automation and value-based approaches, while emerging economies drive growth through mobile diagnostic solutions and local manufacturing partnerships.

Tariff Impact: Managing Supply Chain and Pricing Pressures

The introduction of new U.S. tariffs in 2025 has added complexity to sourcing reagents, consumables, and diagnostic equipment. As a response, many operators are revising supplier contracts, exploring local or multi-sourcing, and extending equipment life cycles through maintenance and upgrades. These changes are reshaping capital allocation and vendor negotiation strategies, making agile procurement and risk mitigation vital for maintaining consistent laboratory operations.

Methodology & Data Sources

This analysis is underpinned by a rigorous research methodology, combining in-depth interviews with laboratory leaders, surveys of operational managers, and reviews of regulatory and scientific literature. Primary sources validate qualitative trends, while secondary data ensures robust segmentation and benchmarking, with all findings subject to multiple rounds of internal review for consistency and relevance.

Why This Report Matters

  • Enables executive teams to make informed investment and procurement decisions based on comprehensive segmentation and up-to-date industry benchmarking.
  • Provides strategic guidance for adapting to major regulatory, technological, and tariff-related changes impacting operational models and profitability.

Conclusion

Office based labs are set for continued transformation as they balance technological innovation with supply chain resilience. Leaders equipped with targeted insights from this report can position their organizations for sustained growth and operational excellence in a rapidly evolving diagnostic market.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Rapid integration of point-of-care molecular diagnostics to accelerate same-day clinical decision making in office labs
5.2. Strategic partnerships between office based labs and value-based care organizations to optimize patient outcomes and reduce costs
5.3. Deployment of AI-driven diagnostic platforms for predictive testing workflows and operational efficiency improvements in office labs
5.4. Expansion of telehealth-enabled specimen collection services to extend office based lab reach and enhance patient convenience
5.5. Adoption of mobile phlebotomy and on-site sample collection programs to support homebound and remote patient testing needs
5.6. Implementation of digital lab information systems and interoperability standards to streamline data sharing across care networks
5.7. Navigating evolving reimbursement models and regulatory requirements impacting profitability and compliance in office based labs
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Office Based Labs Market, by Technology Type
8.1. Introduction
8.2. Clinical Chemistry
8.2.1. Continuous Flow
8.2.2. Discrete Analyzers
8.3. Coagulation & Hemostasis
8.3.1. Platelet Function Testing
8.3.2. Prothrombin Time INR
8.4. Hematology
8.4.1. Automated Hematology Analyzers
8.4.2. Manual Cell Counters
8.5. Immunoassay
8.5.1. Chemiluminescence
8.5.2. Enzyme-Linked Immunoassay
8.6. Molecular Diagnostics
8.6.1. Fluorescence In Situ Hybridization
8.6.2. Next-Generation Sequencing
8.6.3. Polymerase Chain Reaction
9. Office Based Labs Market, by Test Type
9.1. Introduction
9.2. Point-of-Care Tests
9.2.1. Glucose Monitoring
9.2.2. Lipid Testing
9.3. Routine Tests
9.3.1. Basic Panels
9.3.2. Comprehensive Panels
9.4. Specialized Tests
9.4.1. Biomarker Tests
9.4.2. Genetic Tests
10. Office Based Labs Market, by Product Type
10.1. Introduction
10.2. Automated Analyzers
10.2.1. Discrete
10.2.2. Integrated
10.3. Next-Generation Sequencing
10.3.1. Targeted Panel Sequencing
10.3.2. Whole Genome Sequencing
10.4. Point-of-Care Devices
10.4.1. Benchtop
10.4.2. Handheld
11. Office Based Labs Market, by Application
11.1. Introduction
11.2. Disease Monitoring
11.2.1. Acute Condition Monitoring
11.2.2. Chronic Disease Monitoring
11.3. Healthcare Diagnostics
11.3.1. Infectious Diseases
11.3.2. Oncology Diagnostics
11.4. Preventive Screening
11.4.1. Cardiovascular Screening
11.4.2. Metabolic Screening
12. Office Based Labs Market, by End User
12.1. Introduction
12.2. Hospital Outreach Laboratories
12.3. Independent Reference Laboratories
12.4. Physician Office Laboratories
13. Americas Office Based Labs Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Office Based Labs Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Office Based Labs Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. F. Hoffmann-La Roche Ltd
16.3.2. Danaher Corporation
16.3.3. Abbott Laboratories
16.3.4. Thermo Fisher Scientific Inc.
16.3.5. Siemens Healthineers AG
16.3.6. Sysmex Corporation
16.3.7. Becton, Dickinson and Company
16.3.8. bioMérieux SA
16.3.9. QIAGEN N.V.
16.3.10. Ortho Clinical Diagnostics Inc.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. OFFICE BASED LABS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL OFFICE BASED LABS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL OFFICE BASED LABS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL OFFICE BASED LABS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL OFFICE BASED LABS MARKET SIZE, BY TECHNOLOGY TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL OFFICE BASED LABS MARKET SIZE, BY TECHNOLOGY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL OFFICE BASED LABS MARKET SIZE, BY TEST TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL OFFICE BASED LABS MARKET SIZE, BY TEST TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL OFFICE BASED LABS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL OFFICE BASED LABS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL OFFICE BASED LABS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL OFFICE BASED LABS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL OFFICE BASED LABS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL OFFICE BASED LABS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS OFFICE BASED LABS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS OFFICE BASED LABS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES OFFICE BASED LABS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES OFFICE BASED LABS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA OFFICE BASED LABS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA OFFICE BASED LABS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC OFFICE BASED LABS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC OFFICE BASED LABS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. OFFICE BASED LABS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. OFFICE BASED LABS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. OFFICE BASED LABS MARKET: RESEARCHAI
FIGURE 26. OFFICE BASED LABS MARKET: RESEARCHSTATISTICS
FIGURE 27. OFFICE BASED LABS MARKET: RESEARCHCONTACTS
FIGURE 28. OFFICE BASED LABS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. OFFICE BASED LABS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL OFFICE BASED LABS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL OFFICE BASED LABS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL OFFICE BASED LABS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL OFFICE BASED LABS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL OFFICE BASED LABS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL OFFICE BASED LABS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL OFFICE BASED LABS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL OFFICE BASED LABS MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL OFFICE BASED LABS MARKET SIZE, BY CLINICAL CHEMISTRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL OFFICE BASED LABS MARKET SIZE, BY CLINICAL CHEMISTRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL OFFICE BASED LABS MARKET SIZE, BY CONTINUOUS FLOW, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL OFFICE BASED LABS MARKET SIZE, BY CONTINUOUS FLOW, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL OFFICE BASED LABS MARKET SIZE, BY DISCRETE ANALYZERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL OFFICE BASED LABS MARKET SIZE, BY DISCRETE ANALYZERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL OFFICE BASED LABS MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL OFFICE BASED LABS MARKET SIZE, BY CLINICAL CHEMISTRY, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL OFFICE BASED LABS MARKET SIZE, BY COAGULATION & HEMOSTASIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL OFFICE BASED LABS MARKET SIZE, BY COAGULATION & HEMOSTASIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL OFFICE BASED LABS MARKET SIZE, BY PLATELET FUNCTION TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL OFFICE BASED LABS MARKET SIZE, BY PLATELET FUNCTION TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL OFFICE BASED LABS MARKET SIZE, BY PROTHROMBIN TIME INR, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL OFFICE BASED LABS MARKET SIZE, BY PROTHROMBIN TIME INR, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL OFFICE BASED LABS MARKET SIZE, BY COAGULATION & HEMOSTASIS, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL OFFICE BASED LABS MARKET SIZE, BY COAGULATION & HEMOSTASIS, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL OFFICE BASED LABS MARKET SIZE, BY HEMATOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL OFFICE BASED LABS MARKET SIZE, BY HEMATOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL OFFICE BASED LABS MARKET SIZE, BY AUTOMATED HEMATOLOGY ANALYZERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL OFFICE BASED LABS MARKET SIZE, BY AUTOMATED HEMATOLOGY ANALYZERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL OFFICE BASED LABS MARKET SIZE, BY MANUAL CELL COUNTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL OFFICE BASED LABS MARKET SIZE, BY MANUAL CELL COUNTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL OFFICE BASED LABS MARKET SIZE, BY HEMATOLOGY, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL OFFICE BASED LABS MARKET SIZE, BY HEMATOLOGY, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL OFFICE BASED LABS MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL OFFICE BASED LABS MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL OFFICE BASED LABS MARKET SIZE, BY CHEMILUMINESCENCE, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL OFFICE BASED LABS MARKET SIZE, BY CHEMILUMINESCENCE, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL OFFICE BASED LABS MARKET SIZE, BY ENZYME-LINKED IMMUNOASSAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL OFFICE BASED LABS MARKET SIZE, BY ENZYME-LINKED IMMUNOASSAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL OFFICE BASED LABS MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL OFFICE BASED LABS MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL OFFICE BASED LABS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL OFFICE BASED LABS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL OFFICE BASED LABS MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL OFFICE BASED LABS MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL OFFICE BASED LABS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL OFFICE BASED LABS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL OFFICE BASED LABS MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL OFFICE BASED LABS MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL OFFICE BASED LABS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL OFFICE BASED LABS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL OFFICE BASED LABS MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL OFFICE BASED LABS MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL OFFICE BASED LABS MARKET SIZE, BY POINT-OF-CARE TESTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL OFFICE BASED LABS MARKET SIZE, BY POINT-OF-CARE TESTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL OFFICE BASED LABS MARKET SIZE, BY GLUCOSE MONITORING, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL OFFICE BASED LABS MARKET SIZE, BY GLUCOSE MONITORING, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL OFFICE BASED LABS MARKET SIZE, BY LIPID TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL OFFICE BASED LABS MARKET SIZE, BY LIPID TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL OFFICE BASED LABS MARKET SIZE, BY POINT-OF-CARE TESTS, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL OFFICE BASED LABS MARKET SIZE, BY POINT-OF-CARE TESTS, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL OFFICE BASED LABS MARKET SIZE, BY ROUTINE TESTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL OFFICE BASED LABS MARKET SIZE, BY ROUTINE TESTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL OFFICE BASED LABS MARKET SIZE, BY BASIC PANELS, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL OFFICE BASED LABS MARKET SIZE, BY BASIC PANELS, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL OFFICE BASED LABS MARKET SIZE, BY COMPREHENSIVE PANELS, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL OFFICE BASED LABS MARKET SIZE, BY COMPREHENSIVE PANELS, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL OFFICE BASED LABS MARKET SIZE, BY ROUTINE TESTS, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL OFFICE BASED LABS MARKET SIZE, BY ROUTINE TESTS, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL OFFICE BASED LABS MARKET SIZE, BY SPECIALIZED TESTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL OFFICE BASED LABS MARKET SIZE, BY SPECIALIZED TESTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL OFFICE BASED LABS MARKET SIZE, BY BIOMARKER TESTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL OFFICE BASED LABS MARKET SIZE, BY BIOMARKER TESTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL OFFICE BASED LABS MARKET SIZE, BY GENETIC TESTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL OFFICE BASED LABS MARKET SIZE, BY GENETIC TESTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL OFFICE BASED LABS MARKET SIZE, BY SPECIALIZED TESTS, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL OFFICE BASED LABS MARKET SIZE, BY SPECIALIZED TESTS, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL OFFICE BASED LABS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL OFFICE BASED LABS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL OFFICE BASED LABS MARKET SIZE, BY AUTOMATED ANALYZERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL OFFICE BASED LABS MARKET SIZE, BY AUTOMATED ANALYZERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL OFFICE BASED LABS MARKET SIZE, BY DISCRETE, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL OFFICE BASED LABS MARKET SIZE, BY DISCRETE, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL OFFICE BASED LABS MARKET SIZE, BY INTEGRATED, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL OFFICE BASED LABS MARKET SIZE, BY INTEGRATED, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL OFFICE BASED LABS MARKET SIZE, BY AUTOMATED ANALYZERS, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL OFFICE BASED LABS MARKET SIZE, BY AUTOMATED ANALYZERS, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL OFFICE BASED LABS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL OFFICE BASED LABS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL OFFICE BASED LABS MARKET SIZE, BY TARGETED PANEL SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL OFFICE BASED LABS MARKET SIZE, BY TARGETED PANEL SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL OFFICE BASED LABS MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL OFFICE BASED LABS MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL OFFICE BASED LABS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL OFFICE BASED LABS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL OFFICE BASED LABS MARKET SIZE, BY POINT-OF-CARE DEVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL OFFICE BASED LABS MARKET SIZE, BY POINT-OF-CARE DEVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL OFFICE BASED LABS MARKET SIZE, BY BENCHTOP, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL OFFICE BASED LABS MARKET SIZE, BY BENCHTOP, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL OFFICE BASED LABS MARKET SIZE, BY HANDHELD, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL OFFICE BASED LABS MARKET SIZE, BY HANDHELD, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL OFFICE BASED LABS MARKET SIZE, BY POINT-OF-CARE DEVICES, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL OFFICE BASED LABS MARKET SIZE, BY POINT-OF-CARE DEVICES, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL OFFICE BASED LABS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL OFFICE BASED LABS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL OFFICE BASED LABS MARKET SIZE, BY DISEASE MONITORING, BY REGION, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL OFFICE BASED LABS MARKET SIZE, BY DISEASE MONITORING, BY REGION, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL OFFICE BASED LABS MARKET SIZE, BY ACUTE CONDITION MONITORING, BY REGION, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL OFFICE BASED LABS MARKET SIZE, BY ACUTE CONDITION MONITORING, BY REGION, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL OFFICE BASED LABS MARKET SIZE, BY CHRONIC DISEASE MONITORING, BY REGION, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL OFFICE BASED LABS MARKET SIZE, BY CHRONIC DISEASE MONITORING, BY REGION, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL OFFICE BASED LABS MARKET SIZE, BY DISEASE MONITORING, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL OFFICE BASED LABS MARKET SIZE, BY DISEASE MONITORING, 2025-2030 (USD MILLION)
TABLE 115. GLOBAL OFFICE BASED LABS MARKET SIZE, BY HEALTHCARE DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 116. GLOBAL OFFICE BASED LABS MARKET SIZE, BY HEALTHCARE DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 117. GLOBAL OFFICE BASED LABS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 118. GLOBAL OFFICE BASED LABS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 119. GLOBAL OFFICE BASED LABS MARKET SIZE, BY ONCOLOGY DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 120. GLOBAL OFFICE BASED LABS MARKET SIZE, BY ONCOLOGY DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 121. GLOBAL OFFICE BASED LABS MARKET SIZE, BY HEALTHCARE DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 122. GLOBAL OFFICE BASED LABS MARKET SIZE, BY HEALTHCARE DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 123. GLOBAL OFFICE BASED LABS MARKET SIZE, BY PREVENTIVE SCREENING, BY REGION, 2018-2024 (USD MILLION)
TABLE 124. GLOBAL OFFICE BASED LABS MARKET SIZE, BY PREVENTIVE SCREENING, BY REGION, 2025-2030 (USD MILLION)
TABLE 125. GLOBAL OFFICE BASED LABS MARKET SIZE, BY CARDIOVASCULAR SCREENING, BY REGION, 2018-2024 (USD MILLION)
TABLE 126. GLOBAL OFFICE BASED LABS MARKET SIZE, BY CARDIOVASCULAR SCREENING, BY REGION, 2025-2030 (USD MILLION)
TABLE 127. GLOBAL OFFICE BASED LABS MARKET SIZE, BY METABOLIC SCREENING, BY REGION, 2018-2024 (USD MILLION)
TABLE 128. GLOBAL OFFICE BASED LABS MARKET SIZE, BY METABOLIC SCREENING, BY REGION, 2025-2030 (USD MILLION)
TABLE 129. GLOBAL OFFICE BASED LABS MARKET SIZE, BY PREVENTIVE SCREENING, 2018-2024 (USD MILLION)
TABLE 130. GLOBAL OFFICE BASED LABS MARKET SIZE, BY PREVENTIVE SCREENING, 2025-2030 (USD MILLION)
TABLE 131. GLOBAL OFFICE BASED LABS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 132. GLOBAL OFFICE BASED LABS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 133. GLOBAL OFFICE BASED LABS MARKET SIZE, BY HOSPITAL OUTREACH LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 134. GLOBAL OFFICE BASED LABS MARKET SIZE, BY HOSPITAL OUTREACH LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 135. GLOBAL OFFICE BASED LABS MARKET SIZE, BY INDEPENDENT REFERENCE LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 136. GLOBAL OFFICE BASED LABS MARKET SIZE, BY INDEPENDENT REFERENCE LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 137. GLOBAL OFFICE BASED LABS MARKET SIZE, BY PHYSICIAN OFFICE LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 138. GLOBAL OFFICE BASED LABS MARKET SIZE, BY PHYSICIAN OFFICE LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 139. AMERICAS OFFICE BASED LABS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 140. AMERICAS OFFICE BASED LABS MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 141. AMERICAS OFFICE BASED LABS MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2024 (USD MILLION)
TABLE 142. AMERICAS OFFICE BASED LABS MARKET SIZE, BY CLINICAL CHEMISTRY, 2025-2030 (USD MILLION)
TABLE 143. AMERICAS OFFICE BASED LABS MARKET SIZE, BY COAGULATION & HEMOSTASIS, 2018-2024 (USD MILLION)
TABLE 144. AMERICAS OFFICE BASED LABS MARKET SIZE, BY COAGULATION & HEMOSTASIS, 2025-2030 (USD MILLION)
TABLE 145. AMERICAS OFFICE BASED LABS MARKET SIZE, BY HEMATOLOGY, 2018-2024 (USD MILLION)
TABLE 146. AMERICAS OFFICE BASED LABS MARKET SIZE, BY HEMATOLOGY, 2025-2030 (USD MILLION)
TABLE 147. AMERICAS OFFICE BASED LABS MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 148. AMERICAS OFFICE BASED LABS MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 149. AMERICAS OFFICE BASED LABS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 150. AMERICAS OFFICE BASED LABS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 151. AMERICAS OFFICE BASED LABS MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 152. AMERICAS OFFICE BASED LABS MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 153. AMERICAS OFFICE BASED LABS MARKET SIZE, BY POINT-OF-CARE TESTS, 2018-2024 (USD MILLION)
TABLE 154. AMERICAS OFFICE BASED LABS MARKET SIZE, BY POINT-OF-CARE TESTS, 2025-2030 (USD MILLION)
TABLE 155. AMERICAS OFFICE BASED LABS MARKET SIZE, BY ROUTINE TESTS, 2018-2024 (USD MILLION)
TABLE 156. AMERICAS OFFICE BASED LABS MARKET SIZE, BY ROUTINE TESTS, 2025-2030 (USD MILLION)
TABLE 157. AMERICAS OFFICE BASED LABS MARKET SIZE, BY SPECIALIZED TESTS, 2018-2024 (USD MILLION)
TABLE 158. AMERICAS OFFICE BASED LABS MARKET SIZE, BY SPECIALIZED TESTS, 2025-2030 (USD MILLION)
TABLE 159. AMERICAS OFFICE BASED LABS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 160. AMERICAS OFFICE BASED LABS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 161. AMERICAS OFFICE BASED LABS MARKET SIZE, BY AUTOMATED ANALYZERS, 2018-2024 (USD MILLION)
TABLE 162. AMERICAS OFFICE BASED LABS MARKET SIZE, BY AUTOMATED ANALYZERS, 2025-2030 (USD MILLION)
TABLE 163. AMERICAS OFFICE BASED LABS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 164. AMERICAS OFFICE BASED LABS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 165. AMERICAS OFFICE BASED LABS MARKET SIZE, BY POINT-OF-CARE DEVICES, 2018-2024 (USD MILLION)
TABLE 166. AMERICAS OFFICE BASED LABS MARKET SIZE, BY POINT-OF-CARE DEVICES, 2025-2030 (USD MILLION)
TABLE 167. AMERICAS OFFICE BASED LABS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 168. AMERICAS OFFICE BASED LABS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 169. AMERICAS OFFICE BASED LABS MARKET SIZE, BY DISEASE MONITORING, 2018-2024 (USD MILLION)
TABLE 170. AMERICAS OFFICE BASED LABS MARKET SIZE, BY DISEASE MONITORING, 2025-2030 (USD MILLION)
TABLE 171. AMERICAS OFFICE BASED LABS MARKET SIZE, BY HEALTHCARE DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 172. AMERICAS OFFICE BASED LABS MARKET SIZE, BY HEALTHCARE DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 173. AMERICAS OFFICE BASED LABS MARKET SIZE, BY PREVENTIVE SCREENING, 2018-2024 (USD MILLION)
TABLE 174. AMERICAS OFFICE BASED LABS MARKET SIZE, BY PREVENTIVE SCREENING, 2025-2030 (USD MILLION)
TABLE 175. AMERICAS OFFICE BASED LABS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 176. AMERICAS OFFICE BASED LABS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 177. AMERICAS OFFICE BASED LABS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 178. AMERICAS OFFICE BASED LABS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 179. UNITED STATES OFFICE BASED LABS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 180. UNITED STATES OFFICE BASED LABS MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 181. UNITED STATES OFFICE BASED LABS MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2024 (USD MILLION)
TABLE 182. UNITED STATES OFFICE BASED LABS MARKET SIZE, BY CLINICAL CHEMISTRY, 2025-2030 (USD MILLION)
TABLE 183. UNITED STATES OFFICE BASED LABS MARKET SIZE, BY COAGULATION & HEMOSTASIS, 2018-2024 (USD MILLION)
TABLE 184. UNITED STATES OFFICE BASED LABS MARKET SIZE, BY COAGULATION & HEMOSTASIS, 2025-2030 (USD MILLION)
TABLE 185. UNITED STATES OFFICE BASED LABS MARKET SIZE, BY HEMATOLOGY, 2018-2024 (USD MILLION)
TABLE 186. UNITED STATES OFFICE BASED LABS MARKET SIZE, BY HEMATOLOGY, 2025-2030 (USD MILLION)
TABLE 187. UNITED STATES OFFICE BASED LABS MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 188. UNITED STATES OFFICE BASED LABS MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 189. UNITED STATES OFFICE BASED LABS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 190. UNITED STATES OFFICE BASED LABS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 191. UNITED STATES OFFICE BASED LABS MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 192. UNITED STATES OFFICE BASED LABS MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 193. UNITED STATES OFFICE BASED LABS MARKET SIZE, BY POINT-OF-CARE TESTS, 2018-2024 (USD MILLION)
TABLE 194. UNITED STATES OFFICE BASED LABS MARKET SIZE, BY POINT-OF-CARE TESTS, 2025-2030 (USD MILLION)
TABLE 195. UNITED STATES OFFICE BASED LABS MARKET SIZE, BY ROUTINE TESTS, 2018-2024 (USD MILLION)
TABLE 196. UNITED STATES OFFICE BASED LABS MARKET SIZE, BY ROUTINE TESTS, 2025-2030 (USD MILLION)
TABLE 197. UNITED STATES OFFICE BASED LABS MARKET SIZE, BY SPECIALIZED TESTS, 2018-2024 (USD MILLION)
TABLE 198. UNITED STATES OFFICE BASED LABS MARKET SIZE, BY SPECIALIZED TESTS, 2025-2030 (USD MILLION)
TABLE 199. UNITED STATES OFFICE BASED LABS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 200. UNITED STATES OFFICE BASED LABS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 201. UNITED STATES OFFICE BASED LABS MARKET SIZE, BY AUTOMATED ANALYZERS, 2018-2024 (USD MILLION)
TABLE 202. UNITED STATES OFFICE BASED LABS MARKET SIZE, BY AUTOMATED ANALYZERS, 2025-2030 (USD MILLION)
TABLE 203. UNITED STATES OFFICE BASED LABS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 204. UNITED STATES OFFICE BASED LABS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 205. UNITED STATES OFFICE BASED LABS MARKET SIZE, BY POINT-OF-CARE DEVICES, 2018-2024 (USD MILLION)
TABLE 206. UNITED STATES OFFICE BASED LABS MARKET SIZE, BY POINT-OF-CARE DEVICES, 2025-2030 (USD MILLION)
TABLE 207. UNITED STATES OFFICE BASED LABS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 208. UNITED STATES OFFICE BASED LABS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 209. UNITED STATES OFFICE BASED LABS MARKET SIZE, BY DISEASE MONITORING, 2018-2024 (USD MILLION)
TABLE 210. UNITED STATES OFFICE BASED LABS MARKET SIZE, BY DISEASE MONITORING, 2025-2030 (USD MILLION)
TABLE 211. UNITED STATES OFFICE BASED LABS MARKET SIZE, BY HEALTHCARE DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 212. UNITED STATES OFFICE BASED LABS MARKET SIZE, BY HEALTHCARE DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 213. UNITED STATES OFFICE BASED LABS MARKET SIZE, BY PREVENTIVE SCREENING, 2018-2024 (USD MILLION)
TABLE 214. UNITED STATES OFFICE BASED LABS MARKET SIZE, BY PREVENTIVE SCREENING, 2025-2030 (USD MILLION)
TABLE 215. UNITED STATES OFFICE BASED LABS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 216. UNITED STATES OFFICE BASED LABS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 217. UNITED STATES OFFICE BASED LABS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 218. UNITED STATES OFFICE BASED LABS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 219. CANADA OFFICE BASED LABS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 220. CANADA OFFICE BASED LABS MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 221. CANADA OFFICE BASED LABS MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2024 (USD MILLION)
TABLE 222. CANADA OFFICE BASED LABS MARKET SIZE, BY CLINICAL CHEMISTRY, 2025-2030 (USD MILLION)
TABLE 223. CANADA OFFICE BASED LABS MARKET SIZE, BY COAGULATION & HEMOSTASIS, 2018-2024 (USD MILLION)
TABLE 224. CANADA OFFICE BASED LABS MARKET SIZE, BY COAGULATION & HEMOSTASIS, 2025-2030 (USD MILLION)
TABLE 225. CANADA OFFICE BASED LABS MARKET SIZE, BY HEMATOLOGY, 2018-2024 (USD MILLION)
TABLE 226. CANADA OFFICE BASED LABS MARKET SIZE, BY HEMATOLOGY, 2025-2030 (USD MILLION)
TABLE 227. CANADA OFFICE BASED LABS MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 228. CANADA OFFICE BASED LABS MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 229. CANADA OFFICE BASED LABS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 230. CANADA OFFICE BASED LABS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 231. CANADA OFFICE BASED LABS MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 232. CANADA OFFICE BASED LABS MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 233. CANADA OFFICE BASED LABS MARKET SIZE, BY POINT-OF-CARE TESTS, 2018-2024 (USD MILLION)
TABLE 234. CANADA OFFICE BASED LABS MARKET SIZE, BY POINT-OF-CARE TESTS, 2025-2030 (USD MILLION)
TABLE 235. CANADA OFFICE BASED LABS MARKET SIZE, BY ROUTINE TESTS, 2018-2024 (USD MILLION)
TABLE 236. CANADA OFFICE BASED LABS MARKET SIZE, BY ROUTINE TESTS, 2025-2030 (USD MILLION)
TABLE 237. CANADA OFFICE BASED LABS MARKET SIZE, BY SPECIALIZED TESTS, 2018-2024 (USD MILLION)
TABLE 238. CANADA OFFICE BASED LABS MARKET SIZE, BY SPECIALIZED TESTS, 2025-2030 (USD MILLION)
TABLE 239. CANADA OFFICE BASED LABS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 240. CANADA OFFICE BASED LABS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 241. CANADA OFFICE BASED LABS MARKET SIZE, BY AUTOMATED ANALYZERS, 2018-2024 (USD MILLION)
TABLE 242. CANADA OFFICE BASED LABS MARKET SIZE, BY AUTOMATED ANALYZERS, 2025-2030 (USD MILLION)
TABLE 243. CANADA OFFICE BASED LABS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 244. CANADA OFFICE BASED LABS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 245. CANADA OFFICE BASED LABS MARKET SIZE, BY POINT-OF-CARE DEVICES, 2018-2024 (USD MILLION)
TABLE 246. CANADA OFFICE BASED LABS MARKET SIZE, BY POINT-OF-CARE DEVICES, 2025-2030 (USD MILLION)
TABLE 247. CANADA OFFICE BASED LABS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 248. CANADA OFFICE BASED LABS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 249. CANADA OFFICE BASED LABS MARKET SIZE, BY DISEASE MONITORING, 2018-2024 (USD MILLION)
TABLE 250. CANADA OFFICE BASED LABS MARKET SIZE, BY DISEASE MONITORING, 2025-2030 (USD MILLION)
TABLE 251. CANADA OFFICE BASED LABS MARKET SIZE, BY HEALTHCARE DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 252. CANADA OFFICE BASED LABS MARKET SIZE, BY HEALTHCARE DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 253. CANADA OFFICE BASED LABS MARKET SIZE, BY PREVENTIVE SCREENING, 2018-2024 (USD MILLION)
TABLE 254. CANADA OFFICE BASED LABS MARKET SIZE, BY PREVENTIVE SCREENING, 2025-2030 (USD MILLION)
TABLE 255. CANADA OFFICE BASED LABS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 256. CANADA OFFICE BASED LABS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 257. MEXICO OFFICE BASED LABS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 258. MEXICO OFFICE BASED LABS MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 259. MEXICO OFFICE BASED LABS MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2024 (USD MILLION)
TABLE 260. MEXICO OFFICE BASED LABS MARKET SIZE, BY CLINICAL CHEMISTRY, 2025-2030 (USD MILLION)
TABLE 261. MEXICO OFFICE BASED LABS MARKET SIZE, BY COAGULATION & HEMOSTASIS, 2018-2024 (USD MILLION)
TABLE 262. MEXICO OFFICE BASED LABS MARKET SIZE, BY COAGULATION & HEMOSTASIS, 2025-2030 (USD MILLION)
TABLE 263. MEXICO OFFICE BASED LABS MARKET SIZE, BY HEMATOLOGY, 2018-2024 (USD MILLION)
TABLE 264. MEXICO OFFICE BASED LABS MARKET SIZE, BY HEMATOLOGY, 2025-2030 (USD MILLION)
TABLE 265. MEXICO OFFICE BASED LABS MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 266. MEXICO OFFICE BASED LABS MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 267. MEXICO OFFICE BASED LABS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 268. MEXICO OFFICE BASED LABS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 269. MEXICO OFFICE BASED LABS MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 270. MEXICO OFFICE BASED LABS MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 271. MEXICO OFFICE BASED LABS MARKET SIZE, BY POINT-OF-CARE TESTS, 2018-2024 (USD MILLION)
TABLE 272. MEXICO OFFICE BASED LABS MARKET SIZE, BY POINT-OF-CARE TESTS, 2025-2030 (USD MILLION)
TABLE 273. MEXICO OFFICE BASED LABS MARKET SIZE, BY ROUTINE TESTS, 2018-2024 (USD MILLION)
TABLE 274. MEXICO OFFICE BASED LABS MARKET SIZE, BY ROUTINE TESTS, 2025-2030 (USD MILLION)
TABLE 275. MEXICO OFFICE BASED LABS MARKET SIZE, BY SPECIALIZED TESTS, 2018-2024 (USD MILLION)
TABLE 276. MEXICO OFFICE BASED LABS MARKET SIZE, BY SPECIALIZED TESTS, 2025-2030 (USD MILLION)
TABLE 277. MEXICO OFFICE BASED LABS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 278. MEXICO OFFICE BASED LABS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 279. MEXICO OFFICE BASED LABS MARKET SIZE, BY AUTOMATED ANALYZERS, 2018-2024 (USD MILLION)
TABLE 280. MEXICO OFFICE BASED LABS MARKET SIZE, BY AUTOMATED ANALYZERS, 2025-2030 (USD MILLION)
TABLE 281. MEXICO OFFICE BASED LABS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 282. MEXICO OFFICE BASED LABS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 283. MEXICO OFFICE BASED LABS MARKET SIZE, BY POINT-OF-CARE DEVICES, 2018-2024 (USD MILLION)
TABLE 284. MEXICO OFFICE BASED LABS MARKET SIZE, BY POINT-OF-CARE DEVICES, 2025-2030 (USD MILLION)
TABLE 285. MEXICO OFFICE BASED LABS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 286. MEXICO OFFICE BASED LABS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 287. MEXICO OFFICE BASED LABS MARKET SIZE, BY DISEASE MONITORING, 2018-2024 (USD MILLION)
TABLE 288. MEXICO OFFICE BASED LABS MARKET SIZE, BY DISEASE MONITORING, 2025-2030 (USD MILLION)
TABLE 289. MEXICO OFFICE BASED LABS MARKET SIZE, BY HEALTHCARE DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 290. MEXICO OFFICE BASED LABS MARKET SIZE, BY HEALTHCARE DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 291. MEXICO OFFICE BASED LABS MARKET SIZE, BY PREVENTIVE SCREENING, 2018-2024 (USD MILLION)
TABLE 292. MEXICO OFFICE BASED LABS MARKET SIZE, BY PREVENTIVE SCREENING, 2025-2030 (USD MILLION)
TABLE 293. MEXICO OFFICE BASED LABS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 294. MEXICO OFFICE BASED LABS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 295. BRAZIL OFFICE BASED LABS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 296. BRAZIL OFFICE BASED LABS MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 297. BRAZIL OFFICE BASED LABS MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2024 (USD MILLION)
TABLE 298. BRAZIL OFFICE BASED LABS MARKET SIZE, BY CLINICAL CHEMISTRY, 2025-2030 (USD MILLION)
TABLE 299. BRAZIL OFFICE BASED LABS MARKET SIZE, BY COAGULATION & HEMOSTASIS, 2018-2024 (USD MILLION)
TABLE 300. BRAZIL OFFICE BASED LABS MARKET SIZE, BY COAGULATION & HEMOSTASIS, 2025-2030 (USD MILLION)
TABLE 301. BRAZIL OFFICE BASED LABS MARKET SIZE, BY HEMATOLOGY, 2018-2024 (USD MILLION)
TABLE 302. BRAZIL OFFICE BASED LABS MARKET SIZE, BY HEMATOLOGY, 2025-2030 (USD MILLION)
TABLE 303. BRAZIL OFFICE BASED LABS MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 304. BRAZIL OFFICE BASED LABS MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 305. BRAZIL OFFICE BASED LABS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 306. BRAZIL OFFICE BASED LABS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 307. BRAZIL OFFICE BASED LABS MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 308. BRAZIL OFFICE BASED LABS MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 309. BRAZIL OFFICE BASED LABS MARKET SIZE, BY POINT-OF-CARE TESTS, 2018-2024 (USD MILLION)
TABLE 310. BRAZIL OFFICE BASED LABS MARKET SIZE, BY POINT-OF-CARE TESTS, 2025-2030 (USD MILLION)
TABLE 311. BRAZIL OFFICE BASED LABS MARKET SIZE, BY ROUTINE TESTS, 2018-2024 (USD MILLION)
TABLE 312. BRAZIL OFFICE BASED LABS MARKET SIZE, BY ROUTINE TESTS, 2025-2030 (USD MILLION)
TABLE 313. BRAZIL OFFICE BASED LABS MARKET SIZE, BY SPECIALIZED TESTS, 2018-2024 (USD MILLION)
TABLE 314. BRAZIL OFFICE BASED LABS MARKET SIZE, BY SPECIALIZED TESTS, 2025-2030 (USD MILLION)
TABLE 315. BRAZIL OFFICE BASED LABS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 316. BRAZIL OFFICE BASED LABS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 317. BRAZIL OFFICE BASED LABS MARKET SIZE, BY AUTOMATED ANALYZERS, 2018-2024 (USD MILLION)
TABLE 318. BRAZIL OFFICE BASED LABS MARKET SIZE, BY AUTOMATED ANALYZERS, 2025-2030 (USD MILLION)
TABLE 319. BRAZIL OFFICE BASED LABS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 320. BRAZIL OFFICE BASED LABS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 321. BRAZIL OFFICE BASED LABS MARKET SIZE, BY POINT-OF-CARE DEVICES, 2018-2024 (USD MILLION)
TABLE 322. BRAZIL OFFICE BASED LABS MARKET SIZE, BY POINT-OF-CARE DEVICES, 2025-2030 (USD MILLION)
TABLE 323. BRAZIL OFFICE BASED LABS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 324. BRAZIL OFFICE BASED LABS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 325. BRAZIL OFFICE BASED LABS MARKET SIZE, BY DISEASE MONITORING, 2018-2024 (USD MILLION)
TABLE 326. BRAZIL OFFICE BASED LABS MARKET SIZE, BY DISEASE MONITORING, 2025-2030 (USD MILLION)
TABLE 327. BRAZIL OFFICE BASED LABS MARKET SIZE, BY HEALTHCARE DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 328. BRAZIL OFFICE BASED LABS MARKET SIZE, BY HEALTHCARE DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 329. BRAZIL OFFICE BASED LABS MARKET SIZE, BY PREVENTIVE SCREENING, 2018-2024 (USD MILLION)
TABLE 330. BRAZIL OFFICE BASED LABS MARKET SIZE, BY PREVENTIVE SCREENING, 2025-2030 (USD MILLION)
TABLE 331. BRAZIL OFFICE BASED LABS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 332. BRAZIL OFFICE BASED LABS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 33

Samples

Loading
LOADING...

Companies Mentioned

  • F. Hoffmann-La Roche Ltd
  • Danaher Corporation
  • Abbott Laboratories
  • Thermo Fisher Scientific Inc.
  • Siemens Healthineers AG
  • Sysmex Corporation
  • Becton, Dickinson and Company
  • bioMérieux SA
  • QIAGEN N.V.
  • Ortho Clinical Diagnostics Inc.

Table Information

Report AttributeDetails
No. of Pages192
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 55.16 Billion
Forecasted Market Value ( USD ) by 2030 $ 83.05 Billion
Compound Annual Growth Rate8.5%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Office-based Labs - Global Strategic Business Report - Product Image

Office-based Labs - Global Strategic Business Report

  • Report
  • 279 Pages
  • Global
From
Diagnostic Laboratory Test Market by Test Type (Clinical Chemistry, Hematology, Immunoassay), End User (Clinics, Hospitals, Physician Office Laboratories), Technology, Disease Type, Application - Global Forecast 2025-2030 - Product Image

Diagnostic Laboratory Test Market by Test Type (Clinical Chemistry, Hematology, Immunoassay), End User (Clinics, Hospitals, Physician Office Laboratories), Technology, Disease Type, Application - Global Forecast 2025-2030

  • Report
  • 185 Pages
  • Global
From
Clinical Laboratory Services Market by Service Type, Technology, Disease Category, Sample Type, End User - Global Forecast 2025-2030 - Product Image

Clinical Laboratory Services Market by Service Type, Technology, Disease Category, Sample Type, End User - Global Forecast 2025-2030

  • Report
  • 196 Pages
  • Global
From
Clinical Laboratory Services - Global Strategic Business Report - Product Image

Clinical Laboratory Services - Global Strategic Business Report

  • Report
  • 494 Pages
  • Global
From
Primary Care PoC Diagnostics Market Size, Share & Trends Analysis Report By Disease (Hb1Ac Testing, Coagulation Testing, Fertility/Pregnancy), By End-use, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Primary Care PoC Diagnostics Market Size, Share & Trends Analysis Report By Disease (Hb1Ac Testing, Coagulation Testing, Fertility/Pregnancy), By End-use, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 100 Pages
  • Global
From

About the Office Based Lab Market

The Office Based Lab (OBL) market is a subset of the in-office testing market, which focuses on providing laboratory services within a physician's office. OBLs provide a range of services, including clinical chemistry, hematology, immunology, and molecular diagnostics. These services are typically used to diagnose and monitor a variety of conditions, such as diabetes, heart disease, and infectious diseases. OBLs are typically equipped with the necessary equipment and supplies to perform tests, as well as trained personnel to interpret the results. OBLs offer a number of advantages over traditional laboratory services, including improved patient convenience, faster turnaround times, and cost savings. Additionally, OBLs can provide physicians with more timely and accurate information to help them make better decisions about patient care. Some companies in the OBL market include Abbott Laboratories, Roche Diagnostics, Siemens Healthineers, and Quest Diagnostics. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.